...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Prostate Ca / Brd4

New abstract linking them

 

Med. 2019 Feb 19. doi: 10.1002/cam4.2029. [Epub

Share
New Message
Please login to post a reply